Skip to content
lifestyle.washingtonguardian.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
T-MAXIMUM PHARMACEUTICAL
T-MAXIMUM B7-H3-Targeted Allogeneic CAR-T Therapy MT027 Receives FDA Fast Track Designation, Accelerating Global Development for Intracranial Solid Tumors
August 31, 2026
The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena — Who Is Leading?
July 21, 2026